<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Dkfz on BEHIND-MS</title>
    <link>https://www.behind-ms.eu/en/tags/dkfz/</link>
    <description>Recent content in Dkfz on BEHIND-MS</description>
    <generator>Hugo</generator>
    <language>en</language>
    <lastBuildDate>Wed, 15 May 2024 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.behind-ms.eu/en/tags/dkfz/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Principal Investigator - German Cancer Research Center</title>
      <link>https://www.behind-ms.eu/en/teams/pi-dkfz/</link>
      <pubDate>Sun, 12 May 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/teams/pi-dkfz/</guid>
      <description>&lt;h2 id=&#34;contribution-to-the-project&#34;&gt;Contribution to the project&lt;/h2&gt;&#xA;&lt;p&gt;The team will isolate and characterize the Epstein-Barr viral strains that infect patients with multiple sclerosis. It will also analyse the interactions between the virus, the immune system and the central nervous system.&lt;/p&gt;&#xA;&lt;h2 id=&#34;team-members&#34;&gt;Team Members&lt;/h2&gt;&#xA;&lt;h3 id=&#34;henri-jacques-delecluse---lab-head&#34;&gt;Henri-Jacques Delecluse - Lab head&lt;/h3&gt;&#xA;&lt;p&gt;&lt;img src=&#34;https://www.behind-ms.eu/img/teams/Henri-Jacques-Delecluse.jpg&#34; alt=&#34;Henri-Jacques Delecluse&#34;&gt;&lt;/p&gt;&#xA;&lt;p&gt;Henri-Jacques studied Medicine at the University of Lille, France. He did a specialty in Pathology at the University of Lyon, France. He is head of division at the German Cancer Research Centre (DKFZ) and professor at the |University of Heidelberg since 2003. His research focuses on the genetic analysis of the Epstein-Barr virus functions and they lead to cancer development. More recently, Prof. Delecluse embarked on a new project that focuses on the interactions between the Epstein-Barr virus, the central nervous system and the immune system.&lt;/p&gt;</description>
    </item>
    <item>
      <title>German Cancer Research Center (DKFZ), HI-STEM - Institute for Stem Cell Technology</title>
      <link>https://www.behind-ms.eu/en/teams/dkfz/</link>
      <pubDate>Wed, 15 May 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/teams/dkfz/</guid>
      <description>&lt;h2 id=&#34;contribution-to-the-project&#34;&gt;Contribution to the project&lt;/h2&gt;&#xA;&lt;p&gt;Our group&amp;rsquo;s expertise lies in the direct reprogramming of adult human cells into neural progenitors and the development of sophisticated protocols to generate a wide variety of neural tissues from these cells. In this project, using cells from MS patients, we will first generate a comprehensive bank of reprogrammed patient stem cells, a much-needed resource for both our project and other researchers in the field. We will then derive neural organoids from these stem cells, with a particular focus on modelling the niche that is predominantly affected in multiple sclerosis. Using these organoids, we will develop an acute MS neural injury model and perform transplants into prodromal MS mouse models, with the ultimate goal of understanding the underlying disease mechanisms and identifying new avenues for treatment.&lt;/p&gt;</description>
    </item>
    <item>
      <title>European Multiple Sclerosis Platform</title>
      <link>https://www.behind-ms.eu/en/teams/emsp/</link>
      <pubDate>Sat, 11 May 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/teams/emsp/</guid>
      <description>&lt;h2 id=&#34;contribution-to-the-project&#34;&gt;Contribution to the project:&lt;/h2&gt;&#xA;&lt;p&gt;EMSP is leading on the Communication and Dissemination Work Package to ensure that complex research notions that the research consortium partners are leading on is translated in a user-friendly, more accessible manner to provide updates to people with MS, their caregivers and patient organisations. This will include, but not limited to, leading on the development of communication material such brochures and videos with project updates, updating content on the project’s website and social media platforms dedicated to people with MS, and organisation of livestreamed discussions to bring in together people with MS and researchers and healthcare professionals. EMSP will also support consortium partners to know more on effective engagement of people with MS, this way this practice becomes more common among researchers. In other work packages, EMSP will share the relevant, unique sections of this research with its member organisations to further disseminate the reach of the research to interested people with MS.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
